Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Intralesional triamcinolone acetonide is more effective than platelet-rich plasma for treating scalp alopecia areata.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Regulatory T cells are essential for normal and improved wound healing in mice.

Activated PRP is unnecessary for treating alopecia areata; both activated and non-activated PRP are equally effective and safe.

Platelet-rich plasma treatment significantly increased hair regrowth and decreased discomfort in alopecia patients, making it a potentially better and safer treatment option.

Aconiti Lateralis Preparata Radix helps mouse stem cells grow and turn into bone cells faster than usual methods.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

PRP is a promising, cost-effective treatment for hair loss by stimulating hair growth.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Autologous micrografting via the Rigenera® system shows promise in improving hair loss treatment.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Revertant cell therapy shows promise for treating type XVII collagen deficiency, but better cell selection methods are needed.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Cord blood fraction heals skin wounds as effectively as Actovegin.

PCA hydrogel promotes hair growth by enhancing blood vessel formation and hair follicle stem cell activity.

AH-001 could be a safer and more effective treatment for hair loss.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Intramuscular triamcinolone acetonide is an effective treatment for severe alopecia areata, especially in males.

TAT-GILZ peptide promotes hair growth by boosting stem cell activity.

Botulinum toxin A can help improve thin endometrium and embryo implantation.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Activated PRP injections are effective in treating hair loss and improving hair density.

Freeze-drying collagen-activated PRP increases TGF-β1 levels, enhancing tissue regeneration potential.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Platelet concentrates may help tissue regeneration and have potential for regenerative therapies.

A JAK1 variant causes hair loss, skin issues, and thyroid disease, but treatment with a specific inhibitor can help.